Nom du produit:6-cyclopropylpyridazin-3(2H)-one

IUPAC Name:6-cyclopropyl-2,3-dihydropyridazin-3-one

CAS:1161737-33-2
Formule moléculaire:C7H8N2O
Pureté:95%+
Numéro de catalogue:CM130727
Poids moléculaire:136.15

Unité d'emballage Stock disponible Prix($) Quantité
CM130727-1g in stock ħij
CM130727-5g in stock ǎħŌ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1161737-33-2
Formule moléculaire:C7H8N2O
Point de fusion:-
Code SMILES:O=C1C=CC(C2CC2)=NN1
Densité:
Numéro de catalogue:CM130727
Poids moléculaire:136.15
Point d'ébullition:
N° Mdl:MFCD16871334
Stockage:Store at 2-8°C.

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.
Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.

Column Infos